Dr. Daniel J. Lama, MD

Dr. Lama practices at San Bernardino Urological in Apple Valley, California.

Dr. Lama's NPI, 1235634676, was assigned on March 28, 2018. Dr. Lama graduated from UC Irvine School of Medicine in 2018. Dr. Lama holds California license A184669.

Dr. Lama's primary practice is San Bernardino Urological, at 15995 Tuscola Rd, Apple Valley, CA 92307 in San Bernardino County. The practice phone is (909) 882-2973.

Dr. Lama's primary practice is San Bernardino Urological in Apple Valley, California. Dr. Lama is also affiliated with Dignity Health - St. Bernardine Medical Center. The medical group on file is San Bernardino Urological Associates Medical Group. Dmand AI also links Dr. Lama to 1 more hospital, 1 group practice or clinic, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lama practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Lama's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Lama's licenses on file in 2 states: California and Ohio.

Dmand AI lists enlarged prostate transurethral surgery (TURP) and urinary endoscopy among the conditions Dr. Lama treats.

CMS data shows 71 Medicare services from Dr. Lama across 3 procedure codes in 2024, for 95 Medicare patients. Medicare paid $7,223 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 95 Medicare patients who saw Dr. Lama in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have cancer, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lama's median patient age at 67, with 30% women.

In 2024, Dr. Lama wrote 80 Medicare Part D claims for 47 patients. 100% of them were for generic drugs. CMS names the drug for 56 of them, across 3 drugs with 11 or more claims each, at $86 in total drug cost. In 2022, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Lama for performance year 2024, reported as part of a group. Dr. Lama accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lama as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Lama, published from 2018 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Ureteroscopy and Carcinoma, Transitional Cell. Dr. Lama has published most often in J Endourol. Dr. Lama's most frequent co-authors are Daniel J. Lama, MD, Ralph V. Clayman, MD and Jaime Landman, MD.

CMS Open Payments shows 29 general payments to Dr. Lama from 15 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $218.

Dr. Lama graduated from UC Irvine School of Medicine in 2018.

Dr. Lama is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.